Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 27;14(12):1515.
doi: 10.3390/biom14121515.

Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders

Ludovica Franceschin  1 , Alessia Guidotti  1 , Roberto Mazzetto  1 , Jacopo Tartaglia  1 , Christian Ciolfi  1 , Mauro Alaibac  1 , Alvise Sernicola  1
Affiliations
Review

Repurposing Historic Drugs for Neutrophil-Mediated Inflammation in Skin Disorders

Ludovica Franceschin et al. Biomolecules. .

Abstract

Neutrophil-mediated inflammation is a key feature of immune-mediated chronic skin disorders, but the mechanistic understanding of neutrophil involvement in these conditions remains incomplete. Dapsone, colchicine, and tetracyclines are established drugs within the dermatologist's therapeutic armamentarium that are credited with potent anti-neutrophilic effects. Anti-neutrophilic drugs have established themselves as versatile agents in the treatment of a wide range of dermatological conditions. Some of these agents are approved for the management of specific dermatologic conditions, but most of their current uses are off-label and only supported by isolated reports or case series. Their anti-inflammatory and immunomodulatory properties make them particularly valuable in managing auto-immune bullous diseases, neutrophilic dermatoses, eosinophilic dermatoses, interface dermatitis, and granulomatous diseases that are the focus of this review. By inhibiting inflammatory pathways, reducing cytokine production, and modulating immune responses, they contribute significantly to the treatment and management of these complex skin conditions. Their use continues to evolve as our understanding of these diseases deepens, and they remain a cornerstone of dermatological therapy.

Keywords: autoimmune bullous disorders; colchicine; dapsone; hidradenitis suppurativa; neutrophils; psoriasis; pyoderma gangrenosum; tetracycline.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Yang M., Wu H., Zhao M., Chang C., Lu Q. The Pathogenesis of Bullous Skin Diseases. J. Transl. Autoimmun. 2019;2:100014. doi: 10.1016/j.jtauto.2019.100014. - DOI - PMC - PubMed
    1. Borradori L., Van Beek N., Feliciani C., Tedbirt B., Antiga E., Bergman R., Böckle B.C., Caproni M., Caux F., Chandran N.S., et al. Updated S2 K Guidelines for the Management of Bullous Pemphigoid Initiated by the European Academy of Dermatology and Venereology (EADV) Acad. Dermatol. Venereol. 2022;36:1689–1704. doi: 10.1111/jdv.18220. - DOI - PubMed
    1. Costan V.-V., Popa C., Hâncu M., Porumb-Andrese E., Toader M. Comprehensive Review on the Pathophysiology, Clinical Variants and Management of Pemphigus (Review) Exp. Ther. Med. 2021;22:1335. doi: 10.3892/etm.2021.10770. - DOI - PMC - PubMed
    1. Delaleu J., Lepelletier C., Calugareanu A., De Masson A., Charvet E., Petit A., Giurgea I., Amselem S., Karabina S., Jachiet M., et al. Neutrophilic Dermatoses. La Rev. De Médecine Interne. 2022;43:727–738. doi: 10.1016/j.revmed.2022.06.007. - DOI - PubMed
    1. Villarreal-Villarreal C.D., Ocampo-Candiani J., Villarreal-Martínez A. Sweet Syndrome: A Review and Update. Actas Dermo-Sifiliográficas (Engl. Ed.) 2016;107:369–378. doi: 10.1016/j.adengl.2016.05.021. - DOI - PubMed

LinkOut - more resources